ARIAD Added to Russell Equity Indexes.Business Editors CAMBRIDGE, Mass.--(BUSINESS WIRE)--July 11, 2000 ARIAD ARIAD Allison Research Index of Art and Design Pharmaceuticals, Inc. (Nasdaq: ARIA) today announced that the Company has been included in the newly reconstituted Russell 3000(R) Index, which is made up of the 3000 largest companies in the United States stock market by market capitalization Market Capitalization A measure of a public company's size. Market capitalization is the total dollar value of all outstanding shares. It's calculated by multiplying the number of shares times the current market price. This term is often referred to as market cap. . ARIAD also has been added to the widely used Russell 2000(R) Index of "small-cap" companies. The Russell equity indexes, which are updated on a yearly basis, serve as benchmarks of market performance against which money managers and other mutual funds can be evaluated. More than $177 billion is invested in index funds that use the Russell indexes Russell Indexes US equity index widely used by pension and mutual fund investors that are weighted by market capitalization and published by the Frank Russell Company of Tacoma, Washington. as a model to direct investments. In addition, $60 billion is invested globally in the Russell family of mutual funds. The health care sector, as tracked by the Russell equity indexes, had a greater total return than any other industry sector in the second quarter of 2000. "We anticipate that ARIAD's inclusion in the Russell 2000 Index Russell 2000 Index An index measuring the performance of the 2,000 smallest companies in the Russell 3000 Index, which is made up of 3,000 of the biggest U.S. stocks. The Russell 2000 serves as a benchmark for small-cap stocks in the United States. should attract new shareholders who invest in diversified small-cap index funds," said Harvey J. Berger, M.D., chairman and chief executive officer of ARIAD. ARIAD Pharmaceuticals, Inc. (www.ariad.com) is a leader in the discovery and development of gene therapy, cell therapy, stem cell therapy stem cell therapy Cell therapy Molecular medicine A technology in which a person's own cells–eg, neuronal stem cells are triggered to revert to their primitive embryonic form, then redifferentiate into mature cells of various organs and protein therapy products featuring dose-dependent regulation by small-molecule drugs, as well as small-molecule inhibitors of signal transduction. Frank Russell Company (www.russell.com) offers investment planning and advisory services advisory services advisory services provided to the public, in their capacity as owners and managers of animals, are an important part of veterinary science. They may be provided by government bureaux, by commercial companies who deal in pharmaceuticals or animals or animal and diversified mutual funds to individual and institutional investors in thirty-five countries. Some of the matters discussed in this news release are forward-looking statements that involve risks and uncertainties, which include, but are not limited to, risks and uncertainties relating to economic conditions, markets, products, competition, intellectual property, services and prices, key employees, future capital needs, dependence on our collaborators and other factors under the heading "Cautionary Statement Regarding Forward-Looking Statements" in ARIAD's Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the fiscal year ended December 31, 1999 filed with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion